Teladoc Health (TDOC) Depreciation & Amortization (CF) (2014 - 2023)

Teladoc Health (TDOC) has 10 years of Depreciation & Amortization (CF) data on file, last reported at $94.3 million in Q3 2023.

• For the quarter ending Q3 2023, Depreciation & Amortization (CF) rose 52.08% year-over-year to $94.3 million; the trailing twelve-month figure through Jun 2024 stood at $94.3 million (down 66.67% YoY), and the FY2022 full-year result was $256.0 million, up 25.36% from the prior year.
• Depreciation & Amortization (CF) improved to $94.3 million in Q3 2023, from $75.5 million in the prior quarter.
• In the past five years, Depreciation & Amortization (CF) ranged from a high of $94.3 million in Q3 2023 to a low of $5.1 million in Q4 2019.
• A 5-year average of $42.5 million and a median of $51.3 million in 2021 frame the typical range for Depreciation & Amortization (CF).
• Across the five-year window, Depreciation & Amortization (CF) plunged 46.72% in 2019 and soared 625.84% in 2020, its largest moves.
• Tracing TDOC's Depreciation & Amortization (CF) over 5 years: stood at $5.1 million in 2019, then soared by 625.84% to $37.0 million in 2020, then surged by 41.59% to $52.3 million in 2021, then surged by 44.68% to $75.7 million in 2022, then increased by 24.55% to $94.3 million in 2023.
• Business Quant data shows TDOC's Depreciation & Amortization (CF) at $94.3 million in Q3 2023, $75.5 million in Q2 2023, and $69.8 million in Q1 2023.